MYOCARDIAL TOXIC EFFECTS DURING RECOMBINANT INTERLEUKIN-2 THERAPY

被引：82

作者：

NORA, R

ABRAMS, JS

TAIT, NS

HIPONIA, DJ

SILVERMAN, HJ

机构：

[1] UNIV MARYLAND,SCH MED & MED SYST,CTR CANC,DEPT MED,DIV MED ONCOL,BALTIMORE,MD 21201

[2] UNIV MARYLAND,SCH MED & MED SYST,CTR CANC,DEPT MED,DIV PULM MED,BALTIMORE,MD 21201

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 01期

关键词：

D O I：

10.1093/jnci/81.1.59

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：59 / 63

页数：5

共 20 条

[1] EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].

BELLDEGRUN, A ;

WEBB, DE ;

AUSTIN, HA ;

STEINBERG, SM ;

WHITE, DE ;

LINEHAN, WM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822

[2]

DUTCHER JP, 1987, P AN M AM SOC CLIN, V6, P246

[3]

ETTINGHAUSEN SE, 1987, BLOOD, V69, P1654

[4]

FISHER RI, 1987, P AN M AM SOC CLIN, V6, P244

[5] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS [J].

GRIMM, EA ;

RAMSEY, KM ;

MAZUMDER, A ;

WILSON, DJ ;

DJEU, JY ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :884-897

[6]

JESMOK G, 1988, P AM ASSOC CANC RES, V29, P435

[7]

LOTZE MT, 1986, CANCER, V58, P2764, DOI 10.1002/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO

[8]

2-Z

[9]

MARGOLIN K, 1987, P AN M AM SOC CLIN, V6, P251

[10]

NORA R, 1987, NEW ENGL J MED, V316, P275

← 1 2 →